Dutch Ministry of Finance reports: Dutch tobacco tax revenue stagnates, mainly due to cross-border consumption shift

Sep.24.2025
Dutch Ministry of Finance reports: Dutch tobacco tax revenue stagnates, mainly due to cross-border consumption shift
A report released by the Dutch Ministry of Finance indicates that tobacco tax increases have failed to boost fiscal revenue. The previously projected €7 million in revenue from a 5 cent per pack tax increase has now fallen to zero, primarily due to cross-border cigarette purchases. The current excise tax on cigarettes is €7.81 per pack, with no further increases planned. Tobacco tax revenue is projected to reach €2.5 billion in both 2025 and 2026.

Key points:

 

·Tax revenue increase effect returns to zero: Netherlands had previously estimated that increasing taxes by 5 cents per pack of cigarettes could generate an additional revenue of 7 million euros, but now that expected amount has dropped to zero. 

·The tobacco tax revenue for both 2025 and 2026 is estimated to be 25 billion euros each, with no further plans for tax hikes. 

·Cross-border cigarette purchases are a key reason: Customs data shows that in 2024, 45% of seized cigarettes lacked the Dutch consumption tax stamp, with many of these cigarettes being purchased from low-tax countries, and over 10% being counterfeit products, which in turn lowers domestic cigarette sales. 

·Public health impact: Data from the National Institute for Public Health and the Environment in the Netherlands (RIVM) shows that after the last tobacco tax hike, 7% of smokers quit smoking, 22% reduced their smoking consumption, and about two-thirds of people attributed changes in behavior to the tax increase.

 


 

2Firsts, September 24, 2025 - According to a recent report by NL Times, the Dutch Ministry of Finance has announced that increasing tobacco taxes will no longer generate additional revenue for the government, largely due to the prevalence of cross-border cigarette purchases.

 

Previously, the Dutch Ministry of Finance estimated that increasing taxes on each pack of cigarettes by 5 euro cents could generate an additional revenue of 7 million euros for the treasury. However, this expected increase in revenue has now been reduced to zero.

 

The Ministry of Finance stated in the report that "Under the current levels of tobacco consumption tax, further tax increases are expected to lead to changes in public behavior, which will completely offset the additional tax revenue.

 

A spokesperson for Dutch State Secretary Eugène Heijnen explained the phenomenon by stating, "A decrease in smoking rates and a significant reduction in cross-border tobacco purchases have greatly decreased cigarette sales, with cross-border purchasing possibly being the main factor.

 

In 2025, the Dutch Ministry of Finance predicts tobacco tax revenues to be €25 billion, remaining steady in 2026. Currently, the excise tax on each pack of cigarettes is €7.81, and the government has no plans to further increase taxes.

 

Customs data support this claim. An analysis of seized cigarettes in 2024 showed that 45% of cigarette packages were lacking the Dutch consumption tax stamp, a figure that has been steadily increasing from 15% in 2021 and 25% in 2023. These unstamped cigarettes were mostly purchased from countries with lower tax rates, with over 10% being counterfeit products.

 

However, the increase in tobacco taxes has had a positive impact on public health. According to the Netherlands National Institute for Public Health and the Environment (RIVM), after the last tax hike, 7% of smokers chose to quit smoking and 22% of smokers reduced their smoking intake, with about two-thirds of them citing the tax increase as one of the reasons for changing their behavior.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Product | RELX Partners With UK E-Liquid Brand T-Juice for Prime Pro × Red Astaire Bundle in France
Product | RELX Partners With UK E-Liquid Brand T-Juice for Prime Pro × Red Astaire Bundle in France
RELX and UK e-liquid brand T-Juice have launched the Prime Pro × Red Astaire bundle in France, combining the RELX Prime Pro open-system pod device with T-Juice’s signature Red Astaire nicotine salt e-liquid. The collaboration retains the existing Prime Pro hardware platform while using an established flavor brand to create a complete open-system offering. The product appeared in French retail and distribution channels in August 2026 and represents a co-branded retail bundle rather than a new device launch.
Aug.27
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives